Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
MasterCard
MA
CN Stock MarketDetailed Quotes
000078 Shenzhen Neptunus Bioengineering
- 2.27
- +0.02+0.89%
Market Closed Apr 30 15:00 CST
5.97BMarket Cap-4.92P/E (TTM)
2.30High2.24Low136.30KlotVolume2.24Open2.25Pre Close31.01MTurnover0.52%Turnover RatioLossP/E (Static)2.63BShares3.1952wk High3.29P/B5.96BFloat Cap2.0752wk Low2.48Limit Up2.63BShs Float14.30Historical High2.03Limit Down2.67%Amplitude0.40Historical Low--Dividend TTM2.27Avg Price60.78KlotAsk--Div YieldTTM100Lot Size72.73KlotBid
Shenzhen Neptunus Bioengineering News
Haiwang Biotech: 2024 Independent Director Debriefing Report (Zhang Hua)
Neptune Biotech: Announcement of Supervisory Board Resolutions
Haiwang Biotech: Audit Opinions of the Supervisory Board on Matters Related to the 19th Meeting of the 9th Board of Supervisors
Haiwang Biotech: Special note by the Board of Directors on matters covered by the 2024 Unqualified Internal Control Audit Report with highlighted sections
Neptune Biotech: Internal Control Audit Report
Neptune Biotech: Announcement on changes in accounting policies
Kaiwang Biotech: 2024 Report on the Work of the Supervisory Committee
Neptune Biotech: Annual Special Audit Report on Related Party Capital Occupation
Neptune Biotech: Announcement on the Renewal of the 2025 Audit Institution
Neptune Biotech: Internal Control Self-Evaluation Report
Haiwang Biotech: Opinions of the Supervisory Board on the “Special Instructions of the Board of Directors on the 2023 Internal Control Audit Report with Unqualified Opinions on the Highlighted Sections and the Effects of Matters Involved in the Elimination of Implications”
Haiwang Biotech: 2024 Independent Director Debriefing Report (Zhang Weisong)
Haiwang Biotech: 2024 Independent Director Debriefing Report (Wang Huanjun)
Haiwang Biotech: Shenzhen Haiwang Biotech Co., Ltd. Business Income Deduction Status Table Special Verification Report
Neptune Biotech: 2024 Annual Audit Report
Neptune Biotech: Announcement of Board Resolutions
Kaiwang Biotech: Special opinion of the board of directors on the evaluation of the independence of independent directors
Neptune Biotech: Announcement on loans and related transactions provided by related parties to the company
Haiwang Biotech: Opinions of the Supervisory Board on the “Special Instructions of the Board of Directors on Matters Involved in the 2024 Unqualified Internal Control Audit Report with Highlighted Matters”
Haiwang Biotech: Announcement on the company\'s uncompensated losses exceeding one-third of the total paid-up share capital
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts